- Editorial: only steps away from primetime? Hepatitis B virus RNA as a routine marker to guide HBV treatment decisions-authors' replyXia, Muye; Chi, Heng; Janssen, Harry L. A.; Peng, Jie*Alimentary Pharmacology and Therapeutics, 2021, 54(7): 972-973.
- OPTIMAL DUAL CUTOFFS OF LIVER STIFFNESS FOR COMPENSATED ADVANCED CHRONIC LIVER DISEASE IN ONTREATMENT PATIENTS WITH CHRONIC HEPATITIS BWu, Xiaoning; Sun, Yameng; Zhou, Jialing; Chen, Yongpeng; Liu, Chenghai; Xing, Huichun; Jiang, Wei; Zhao, Hong; Wang, Bingqiong; Chen, Shuyan; Meng, Tongtong; Ou, Xiaojuan; You, Hong; Jia, JidongMeeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Boston, MA, 2023-11-10 To 2023-11-14.
- ASSOCIATION BETWEEN SERUM HBV RNA AND RISK OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B PATIENTS UNDER ANTIVIRAL THERAPYLiu, Shi; Deng, Rui; Zhou, Bin; Liang, Xieer; Liu, Zhihong; Peng, Jie; Chen, Jinjun; Zhou, Yuanping; Guo, Yabing; Chen, Yongpeng; Li, Wanying; Shen, Sheng; Lu, Xingyu; Zhao, Siru; Liao, Xingmei; Liang, Hongyan; Lan, Yu; Hou, Jinlin; Fan, Rong; Sun, Jian
期刊论文
Letter to the Editor: Cautious interpretation of the association between finite treatment and better prognosis in initially HBeAg-negative hepatitis B patients with cirrhosis
6阅读
